BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho JG, Kim S, Lee A, Jeong H, Yun E, Choi J, Jeong SJ, Chang W, Oh S, Yoo KH, Lee JB, Yoon S, Lee M, Park JH, Jung MH, Kim S, Kim KH, Suh DS, Choi KU, Choi J, Kim J, Kwon BS. MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer. Molecular Therapy - Nucleic Acids 2022;29:803-822. [DOI: 10.1016/j.omtn.2022.08.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Li Z, Gao Y, Zhao H, Guo J, Liu Z, Yin C, Zhao X, Yue W. Integrating single-cell RNA sequencing and prognostic model revealed the carcinogenicity and clinical significance of FAM83D in ovarian cancer. Front Oncol 2022;12:1055648. [PMID: 36568230 DOI: 10.3389/fonc.2022.1055648] [Reference Citation Analysis]
2 Ismail A, Abulsoud AI, Fathi D, Elshafei A, El-mahdy HA, Elsakka EG, Aglan A, Elkhawaga SY, Doghish AS. The role of miRNAs in Ovarian Cancer Pathogenesis and Therapeutic Resistance - A Focus on Signaling Pathways Interplay. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154222] [Reference Citation Analysis]